A detailed history of Verition Fund Management LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 56,501 shares of PLRX stock, worth $858,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,501
Holding current value
$858,250
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.58 - $15.61 $597,780 - $881,980
56,501 New
56,501 $607,000
Q2 2023

Aug 14, 2023

SELL
$18.12 - $30.56 $418,608 - $705,997
-23,102 Reduced 56.62%
17,700 $320,000
Q1 2023

May 15, 2023

BUY
$18.73 - $36.26 $764,221 - $1.48 Million
40,802 New
40,802 $1.09 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $739M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.